Lineage Cell Therapeutics, Inc. Operating Leases, Rent Expense
Lineage Cell Therapeutics, Inc. (LCTX) reported Operating Leases, Rent Expense of $1.20 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2019-03-14
- Lineage Cell Therapeutics, Inc. operating leases, rent expense for fiscal 2018 was $1.20M, a 9.09% increase from fiscal 2017.
- Lineage Cell Therapeutics, Inc. operating leases, rent expense for fiscal 2017 was $1.10M, a 73233.33% increase from fiscal 2016.
- Lineage Cell Therapeutics, Inc. operating leases, rent expense for fiscal 2016 was $1.50K, a 28.57% decline from fiscal 2015.
- Lineage Cell Therapeutics, Inc. operating leases, rent expense for fiscal 2015 was $2.10K, a 99.89% decline from fiscal 2014.
| Period end | Operating Leases, Rent Expense 12 month | Operating Leases, Rent Expense 12 month as first filed |
|---|---|---|
| 2018-12-31 | $1.20M 10-K · filed 2019-03-14 | |
| 2017-12-31 | $1.10M 10-K · filed 2019-03-14 | $1.10K 10-K · filed 2018-03-15 |
| 2016-12-31 | $1.50K 10-K · filed 2018-03-15 | |
| 2015-12-31 | $2.10K 10-K · filed 2018-03-15 | $2.10M 10-K · filed 2016-03-15 |
| 2014-12-31 | $2.00M 10-K · filed 2016-03-15 | $2.19M 10-K · filed 2015-03-11 |
| 2013-12-31 | $1.60M 10-K · filed 2016-03-15 | $1.60M 10-K · filed 2014-03-17 |
| 2012-12-31 | $1.18M 10-K · filed 2015-03-11 | |
| 2011-12-31 | $1.06M 10-K · filed 2014-03-17 | |
| 2010-12-31 | $656.88K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |